The Edinburgh Genetics team was thrilled to be part of the European Society of Human Genetics (ESHG) 2024 conference in Berlin in June...

Next-generation sequencing (NGS) represents an efficient and reliable method to evaluate the contribution of both common and rare...

Marfan syndrome is a genetic disorder that affects the body's connective tissue, which provides strength, support, and elasticity to...

The emerging discipline of proteogenomics arose from the combination of two molecular biology fields – mass spectrometry (MS)-based...

Since the 1990s cardiovascular genomics has been a popular area of research, heading toward a genome-first approach to the diagnosis and...

Although Africa is a genetically diverse continent there has not been extensive genetic disease mapping of the continent as there has...

Chemotherapy is often aggressive and can provoke severe toxicity and adverse drug reactions (ADR). Noticeable differences also exist in...

Neurology researchers are utilising our market-leading egSEQ library preparation and Exome solutions to understand genetic risk factors...

Although it is widely accepted that genetic testing is an important tool to aid early diagnosis in some patient cohorts, studies have...

Among the most researched pharmacogenes is the CYP gene superfamily (Fukunaga et al., 2021), which influences drug-metabolising enzymes...

Personalised diagnostic and precision medicine for cancer patients involves tailoring each patient’s treatment based on the genomic...

With the continuous discovery of genetic targets correlated with recurrence risk, time to recurrence (TTC) and/or overall survival, it is...